SCHEMBL31164705

SCHEMBL31164705

[O-][S+]1CCc2ncnc(NC3(CO)CCC3)c21

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ BTK Q06187 1/20 0.35
▸ LATS1 O95835 2/20 0.33
▸ LATS2 Q9NRM7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8049916 0.95 JAK2 (0.37) JAK2JAK1BTK
SCHEMBL31622408 0.90 JAK2 (0.32) JAK2JAK1
SCHEMBL30686997 0.85 JAK2 (0.30) JAK2JAK1
SCHEMBL30639342 0.79 LATS1 (0.32) LATS1LATS2
SCHEMBL30639341 0.79 LATS1 (0.32) LATS1LATS2
SCHEMBL31571836 0.79 LATS1 (0.32) LATS1LATS2
SCHEMBL14734142 0.79 LATS1 (0.32) LATS1LATS2
SCHEMBL30758491 0.77 LATS1 (0.30) LATS1LATS2
SCHEMBL14754619 0.77 LATS1 (0.31) LATS1LATS2
SCHEMBL29576569 0.76 LATS1 (0.32) JAK2JAK1LATS1LATS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4596554-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE Suzhou Arkbiopharmaceutical Co., Ltd. (CN) 2025-08-06 — — EP disclosed
CN-119930644-A Phosphodiesterase 4B inhibitor and preparation method and application thereof 合肥医工医药股份有限公司 2025-05-06 — — CN disclosed
WO-2024213089-A1 SUBSTITUTED DIHYDROTHIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海壹迪生物技术有限公司 2024-10-17 — — WO disclosed
WO-2024208225-A1 DIHYDROTHIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 上海壹迪生物技术有限公司 2024-10-10 — — WO disclosed
Send feedback